Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

PURPOSE: Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and as a biomarker for evaluating response to therapy, but lacks established response criteria. A panel of PCa experts in nuclear medicine, rad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Fanti, Stefano, Goffin, Karolien, Hadaschik, Boris A, Herrmann, Ken, Maurer, Tobias, MacLennan, Steven, Oprea-Lager, Daniela E., Oyen, Wim JG, Rouvière, Olivier, Mottet, Nicolas, Bjartell, Anders
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835167/
https://ncbi.nlm.nih.gov/pubmed/32617640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04934-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados